BetaGlue Therapeutics is a startup based in Italy, 1 tracked investor.
Based in Italy, BetaGlue Therapeutics is a startup. Brouky records 1 investor associated with the company.
BetaGlue Therapeutics develops YntraDose, an interventional radiotherapeutic platform that delivers Yttrium-90 microspheres directly into solid tumours to provide localized radiation treatment. The company is clinical-stage and targeting indications including pancreatic and liver cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.